Sign in

CIK 0001125345

  • Non-accelerated filer
  • Smaller reporting company

MACROGENICS INC

Sign in to watch
Ticker
MGNX
Exchange
Nasdaq
Industry
Pharmaceutical Preparations
FY end
Dec 31
Incorporated
DE
Entity type
Operating
Phone
+1 301-251-5172
Business address
9704 MEDICAL CENTER DRIVE, Rockville, MD, 20850
  1. 4 Exercise or conversion SVP, CFO and Secretary acquired 6,516 shares (option exercise)
  2. 4 Open-market sale Sr VP, Clinical Dev. & CMO sold 5,000 shares at $20.00 ($100,000)
  3. 4 Exercise or conversion Sr VP & Chief Business Officer acquired 2,000 shares (option exercise)
  4. 4 Exercise or conversion SVP, CFO and Secretary acquired 3,000 shares (option exercise)
  5. 4 Open-market sale Sr VP, Clinical Dev. & CMO sold 5,000 shares at $20.00 ($100,000)
  6. 3 Insider Initial Statement of Ownership
  7. 4 Derivatives Options or other derivatives
  8. 4 Open-market sale Sr VP, Clinical Dev. & CMO sold 10,000 shares at $20.00 ($200,000)
  9. 4 Exercise or conversion SVP, CFO and Secretary acquired 5,000 shares (option exercise)
  10. 4 Exercise or conversion Sr VP & Chief Business Officer acquired 2,000 shares (option exercise)
  11. 4 Exercise or conversion Sr VP, Research & CSO acquired 53,264 shares (option exercise)
  12. 4 Open-market sale Sr VP, Clinical Dev. & CMO sold 5,000 shares at $20.00 ($100,000)
  13. 3 Insider Initial Statement of Ownership
  14. 4 Derivatives Options or other derivatives
  15. 4 Insider Changes in Ownership
  16. 4 Insider Changes in Ownership
  17. 4 Insider Changes in Ownership
  18. 4 Insider Changes in Ownership
  19. 4 Insider Changes in Ownership
  20. 4 Insider Changes in Ownership

Page 16 of 25 · 484 filings